Publications by authors named "Long Jieran"

Claim this Profile
N
Need Analysis of Clinician-Oriented Integrated Precision Oncology Decision Support Tools: Qualitative Descriptive Study.
Sheng Zheng, Yi Feng, Jieran Long, Xiang Li, Meng Zhang

JMIR Hum Factors· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China.
Guangming Tian, Jun Nie, Ling Dai, Weiheng Hu, Jie Zhang, Jieran Long

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-related myocarditis in patients with lung cancer.
Wenli Cao, Sen Han, Panpan Zhang, Lan Mi, Yang Wang, Jieran Long

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second-line monotherapy for patients with small-cell lung cancer.
Jieran Long, Xuefei Li, Lin Wu, Guohua Yu, Aimin Zang

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab combined docetaxel versus nivolumab in patients with previously treated nonsmall cell lung cancer: a phase 2 study.
Yang Wang, Qianyun Hao, Jun Nie, Ling Dai, Weiheng Hu, Jieran Long

Anticancer Drugs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer.
Panpan Zhang, Minting Ma, Jun Nie, Ling Dai, Weiheng Hu, Jieran Long

Heliyon· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of an endoplasmic reticulum stress-related signature in lung adenocarcinoma by comprehensive bioinformatics analysis.
Yang Wang, Jun Nie, Ling Dai, Weiheng Hu, Sen Han, Jieran Long

BMC Pulm Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment options in advanced thymic carcinoma after failure of platinum-based chemotherapy: A multicenter retrospective study.
Yang Wang, Xuanye Zhang, Dan Tian, Sen Han, Jie Zhang, Jieran Long

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The overall survival benefit in Chinese ALK NSCLC patients received targeted therapies.
Guangming Tian, Xinliang Zhao, Jun Nie, Ling Dai, Weiheng Hu, Jieran Long

J Thorac Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC.
Yang Wang, Jun Nie, Ling Dai, Weiheng Hu, Jie Zhang, Jieran Long

Cancer Immunol Immunother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study.
Jie Zhang, Di Wu, Ziran Zhang, Jieran Long, Guangming Tian

Technol Cancer Res Treat· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion.
Wu Di, Cong Yue, Zhang Ziran, Zhang Jie, Nie Jun, Long Jieran

Future Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of endostatin combined with PT-DC versus bevacizumab combined with PT-DC in the first-line treatment of advanced lung adenocarcinoma: a retrospective propensity score-matched cohort study.
Xiaoling Chen, Jun Nie, Ling Dai, Weiheng Hu, Jie Zhang, Jieran Long

Ann Palliat Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Xiangjuan Ma, Ziran Zhang, Xiaoling Chen, Jie Zhang, Jun Nie, Jieran Long

Thorac Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China.
Xiaoling Chen, Jun Nie, Ling Dai, Weiheng Hu, Jie Zhang, Jieran Long

Front Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification.
Bo Jia, Xinghui Zhao, Di Wu, Zhi Dong, Yujia Chi, Jieran Long

Transl Lung Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer.
Di Wu, Jun Nie, Weiheng Hu, Ling Dai, Jie Zhang, Jieran Long

Int J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment with anlotinib for advanced non-small cell lung cancer.
Di Wu, Jun Nie, Ling Dai, Weiheng Hu, Jie Zhang, Jieran Long

Thorac Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer.
Jie Zhang, Chen Tian, Fang Lv, Jianfei Wang, Wenbo Han, Jieran Long

Cancer Commun (Lond)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma.
Yang Wang, Jun Nie, Ling Dai, Weiheng Hu, Xiaoling Chen, Jieran Long

Thorac Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC.
Di Wu, Li Liang, Ligong Nie, Jun Nie, Ling Dai, Jieran Long

Asia Pac J Clin Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Timing of Brain Radiation Therapy Impacts Outcomes in Patients with 
Non-small Cell Lung Cancer Who Develop Brain Metastases].
Yang Wang, Jian Fang, Jun Nie, Ling Dai, Weiheng Hu, Jieran Long

Zhongguo Fei Ai Za Zhi· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of extended use of platinum-based doublet chemotherapy plus endostatin in patients with advanced nonsmall cell lung cancer.
Weiheng Hu, Jian Fang, Jun Nie, Ling Dai, Jie Zhang, Jieran Long

Medicine (Baltimore)· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics associated with non-small-cell lung cancer harboring ALK rearrangements in Chinese patients.
Guangming Tian, Xinliang Zhao, Jun Nie, Ling Dai, Weiheng Hu, Jieran Long

Future Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effects of Local Radiation Combined with Chemotherapy in the treatment of 
Patients with Extensive-stage Small Cell Lung Cancer].
Di Wu, Jian Fang, Jun Nie, Ling Dai, Xiaoling Chen, Jieran Long

Zhongguo Fei Ai Za Zhi· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis